Dendritic-cell-based therapeutic vaccination against cancer
- 11 February 2005
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Immunology
- Vol. 17 (2), 163-169
- https://doi.org/10.1016/j.coi.2005.02.003
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Cognate CD4+ T cell licensing of dendritic cells in CD8+ T cell immunityNature Immunology, 2004
- Maturation Matters: Importance of Maturation for Antitumor Immunity of Dendritic Cell VaccinesJournal of Clinical Oncology, 2004
- Boosting T Cell-Mediated Immunity to Tyrosinase by Vaccinia Virus-Transduced, CD34+-Derived Dendritic Cell VaccinationClinical Cancer Research, 2004
- Immunotherapy: Bewitched, Bothered, and Bewildered No MoreScience, 2004
- Expansion of Melanoma-specific Cytolytic CD8+ T Cell Precursors in Patients with Metastatic Melanoma Vaccinated with CD34+ Progenitor-derived Dendritic CellsThe Journal of Experimental Medicine, 2004
- Intranodal Administration of Peptide-Pulsed Mature Dendritic Cell Vaccines Results in Superior CD8+T-Cell Function in Melanoma PatientsJournal of Clinical Oncology, 2003
- Induction of an antitumor immunological response by an intratumoral injection of dendritic cells pulsed with genetically engineered Semliki Forest virus to produce interleukin-18 combined with the systemic administration of interleukin-12Journal of Neurosurgery, 2003
- Regulation of Dendritic Cell Migration to the Draining Lymph NodeThe Journal of Experimental Medicine, 2003
- Synergy between tumor immunotherapy and antiangiogenic therapyBlood, 2003
- Intranodal injection of semimature monocyte-derived dendritic cells induces T helper type 1 responses to protein neoantigenBlood, 2003